Apnea, Sleep Clinical Trial
Official title:
Radiofrequency Ablation for Multi-level Obstructive Sleep Apnea: A Single-arm, Multicenter Study
The United States is currently experiencing an increase in the incidence and prevalence of obstructive sleep apnea (OSA). With prevalence in middle-aged adults of 2 to 4% of the population, untreated OSA has been implicated in increased risk for cardiovascular disease, including hypertension and heart failure, daytime sleepiness, and increased risk of motor vehicle accidents. This study was design in order to evaluate the CelonProSleep plus for multi-level radiofrequency ablation (RFA) of the palate and base of tongue as a treatment for mild to moderate obstructive sleep apnea syndrome (OSAS).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04326634 -
Controlled Exercises Effectiveness in Patients With Sleep Apnea
|
N/A | |
Completed |
NCT02898792 -
Remifentanil in Adults With OSA
|
Early Phase 1 | |
Active, not recruiting |
NCT04861038 -
Study Using Negative Pressure to Reduce Apnea
|
N/A | |
Completed |
NCT00252629 -
Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment
|
N/A | |
Completed |
NCT01092780 -
Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010)
|
Phase 1 | |
Completed |
NCT03033901 -
Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome
|
||
Completed |
NCT03034447 -
Sleep Apnea in Asthmatic Children and Teenagers
|
N/A | |
Completed |
NCT03172806 -
Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients
|
||
Completed |
NCT02886156 -
Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial
|
N/A |